Published online Mar 20, 2024. doi: 10.5493/wjem.v14.i1.87551
Peer-review started: August 21, 2023
First decision: November 28, 2023
Revised: December 18, 2023
Accepted: December 26, 2023
Article in press: December 26, 2023
Published online: March 20, 2024
Processing time: 211 Days and 2.7 Hours
Prisons can be a reservoir for infectious diseases, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), due to the very intimate nature of the living spaces and the large number of people forced to share them. Therefore, in this place infectious diseases, including SARS-CoV-2, can be amplified and spread.
The main motivation was to improve epidemiological knowledge, aimed at better understanding what action could be taken to improve the health status of the detained population.
Based on these premises, this study evaluated the epidemiology of SARS-CoV-2 infection in prisons.
This is a cross-sectional study, with health status assessed at a single point in time. The study population was represented by all the inmates present in the prisons of Tuscany on 15 February 2021. Data collection included information on prisoners who underwent nasopharyngeal swab testing for SARS-CoV-2 and the results. Nasopharyngeal swab tests for SARS-CoV-2 were performed between 15 February 2021 and 31 May 2021 for prisoners with symptoms and all new arrivals to the facility. Another section included information on the diagnosis of the disease according to the International Classification of Diseases, Ninth Revision, and Clinical Modification.
A high percentage of prisoners agreed to take the swab. This high adherence was probably due to a perception of risk. A significant association was found only for the risk of SARS-CoV-2 infection among foreigners compared to Italians but the SARS-CoV-2 incidence rate among prisoners is significantly lower than in the general population in Tuscany, probably due to the high level of attention of prison staff towards this public health problem.
Although the control and management of SARS-CoV-2 infection in some prisons was similar to that outside, campaigns to improve disease prevention and screening, and rapid access to health care for the migrant population in prisons are critical to limiting transmission of the virus and subsequent morbidity and mortality in this vulnerable population.
Future research is needed to definitively establish a screening program to manage organized screening programs for high-prevalence infectious diseases in the prison population.